Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00389142 · ClinicalTrials.gov registry record
Identifying Genetic Causes of IC/BPS
A clinical trial of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT00389142: Recruiting study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Boston Children's Hospital.
NCT00389142 is a study of Interstitial Cystitis and Bladder Pain Syndrome that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 1,000 participants, above the 324-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (209% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00389142, a study of Interstitial Cystitis and Bladder Pain Syndrome, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Interstitial cystitis (IC), also called Bladder Pain syndrome (BPS) is a common condition with no known cause or cure. Twin studies and family accounts have suggested that the condition may be genetic or passed down (inherited) from one generation to another. In this study, the investigators are collecting genetic material via blood or saliva and medical information from families in North America in an attempt to identify genetic factors that may cause IC/BPS. The investigators are enrolling inviduals with IC/BPS and their family members (family members with and without IC like symptoms). Travel to Boston not required.
Primary Outcome
Outcome is candidate or causative genes for causing IC/BPS.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital (BCH) - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2006-01-15 |
| Est. Completion | 2030-12-31 |
What NCT00389142 shows while recruiting
NCT00389142 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 324-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (209% higher).
The record links to 2 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 0 interventions.
NCT00389142 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00389142 about?
NCT00389142 is a clinical study titled "Identifying Genetic Causes of IC/BPS". Interstitial cystitis (IC), also called Bladder Pain syndrome (BPS) is a common condition with no known cause or cure. Twin studies and family accounts have suggested that the condition may be genetic or passed down (inherited) from one generation to another. In this study, the investigators are co...
What is the current status of trial NCT00389142?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2006-01-15. Estimated completion is 2030-12-31.
What conditions does trial NCT00389142 study?
This clinical trial studies the following conditions: Interstitial Cystitis, Bladder Pain Syndrome.
Who is sponsoring clinical trial NCT00389142?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00389142 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Interstitial Cystitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00389142's enrollment target sits among peer trials
1,000 3rd of 26 higher than 24 of 26 other Interstitial Cystitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Interstitial Cystitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
RECRUITING · NA
-
Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome
RECRUITING · Phase 1
-
Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome
RECRUITING · NA
-
EPPIC: Easing Pelvic Pain Interventions Clinical Research Program
RECRUITING · NA
-
Amniotic Membrane Therapy for Interstitial Cystitis/Painful Bladder Syndrome
RECRUITING · Phase 2
-
Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI